Press-release for stocks

Prices are updated after-hours

aspire

save search

UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
UBX | $1.48 -0.67% -0.68% 82K

Health Technology

| -1.32% | O: -0.66% H: 0.0% C: -0.67%
ubx1325 aspire extension study

Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| 1.18% | O: 0.29% H: 0.0% C: 0.0%
fda clearance system for ice

Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025Trial's lower-than-expected event rate suggests improved survival outcomes
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
PBLA | News | $0.42 -6.31% 64K

Professional, Scientific, and T...

| 0.0% | O: -4.76% H: 17.5% C: 17.5%
aspire for trial therapeutics

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
CLPT | $5.33 -3.09% -3.19% 59K

Health Technology

| Email alert Add to watchlist
avb-101 first dementia for trial

AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
Published: 2024-04-15 (Crawled : 12:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| 0.97% | O: -0.04% H: 0.0% C: 0.0%
avb-101 first dementia for trial

Panbela Exceeds 50% Enrollment for Aspire Trial in Pancreatic Cancer, Exceeding Anticipated Timelines with Accelerated Momentum
Published: 2024-01-25 (Crawled : 12:00) - globenewswire.com
PBLA | News | $0.42 -6.31% 64K

Professional, Scientific, and T...

| -88.49% | O: 2.47% H: 0.94% C: -13.1%
momentum pancreatic aspire trial

Aspire expands footprint with acquisition – Tees Business
Published: 2024-01-05 (Crawled : 12:00) - spacfeed.com
CPT 4 | $98.86 0.26% 0.0% 1.1M

Finance

| 0.81% | O: -0.81% H: 1.72% C: 1.21%
business acquisition aspire

Aspire North America, LLC Enters Five-Year Exclusive Global Manufacturing and Distribution Agreement with Lifestyle Brand: BrkFst
Published: 2023-12-14 (Crawled : 12:00) - prnewswire.com
ISPR | $5.24 -3.68% -3.82% 49K

| -35.62% | O: 7.69% H: 0.0% C: -4.95%
distribution global aspire agreement

UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DMETopline 16-week data expected in the fourth quarter of 2024
Published: 2023-12-12 (Crawled : 15:30) - biospace.com/
UBX | $1.48 -0.67% -0.68% 82K

Health Technology

| -5.1% | O: 2.55% H: 1.86% C: -1.55%
ubx1325 first expected aspire study

UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME
Published: 2023-12-12 (Crawled : 13:00) - globenewswire.com
UBX | $1.48 -0.67% -0.68% 82K

Health Technology

| -5.1% | O: 2.55% H: 1.86% C: -1.55%
ubx1325 first aspire study

Panbela Announces 2nd Independent Safety Review of the ASPIRE Registration Clinical Trial: Recommended Continuation with no Trial Modification
Published: 2023-11-29 (Crawled : 13:00) - globenewswire.com
PBLA | News | $0.42 -6.31% 64K

Professional, Scientific, and T...

| -95.87% | O: 6.5% H: 19.9% C: -8.43%
continuation review aspire trial

AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations
Published: 2023-10-10 (Crawled : 12:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -4.88% | O: 0.67% H: 0.56% C: -0.01%
avb-101 dementia

Mesa Airlines Launches Independent Pilot Time Building Program for Aspiring Pilots
Published: 2023-10-09 (Crawled : 20:00) - globenewswire.com
MESA | $0.9052 0.47% 0.46% 130K

Transportation

| 9.62% | O: 1.1% H: 5.0% C: 4.81%
airlines program pilot

Goosehead Insurance Introduces an Agency Launch Program to Champion Aspiring Entrepreneurs
Published: 2023-08-24 (Crawled : 14:00) - globenewswire.com
GSHD | $60.2 0.27% 0.27% 370K

Finance

| 0.1% | O: -0.91% H: 0.0% C: 0.0%
program insurance

Aspiration Deferred
Published: 2023-08-23 (Crawled : 13:30) - spacfeed.com
BUJA | $10.55 -0.09% 3

n/a

| 3.73% | O: 0.1% H: 0.0% C: 0.0%
MRAI | $2.15 1.18% 1.16% 27K

| 91.89% | O: -2.7% H: 3.7% C: -1.85%

Fox Factory Releases 2022 Sustainability Report, Detailing 2030 Aspirations
Published: 2023-07-26 (Crawled : 20:00) - globenewswire.com
FOXF | $39.885 -1.86% -1.89% 710K

Consumer Durables

| -64.02% | O: 0.86% H: 0.59% C: -4.35%
factory

Panbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer, All Countries/Regions in the Aspire Trial are Now Open and Actively Enrolling
Published: 2023-07-24 (Crawled : 12:20) - globenewswire.com
PBLA | News | $0.42 -6.31% 64K

Professional, Scientific, and T...

| -80.65% | O: 0.0% H: 0.0% C: -5.07%
germany pancreatic aspire trial

Panbela Announces Preliminary Safety Analysis for ASPIRE Trial
Published: 2023-07-10 (Crawled : 12:20) - globenewswire.com
PBLA | News | $0.42 -6.31% 64K

Professional, Scientific, and T...